This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Pharmalucence, Inc., a specialty pharmaceutical company focused on manufacturing and distributing generic radiopharmaceutical products and supplies. The contract, worth up to $80,000.00, is for the delivery of various radiopharmaceuticals to military treatment facilities to support nuclear medicine diagnostic services for active duty...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $202,467.88, is for the supply of radiopharmaceuticals, including specialized medical isotopes such as technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as radiopharmaceutical therapies like Xofigo (radium-223 dichloride) for prostate cancer treatment. This...
This is a $145,800 firm fixed price purchase order awarded by the Defense Health Agency to Advanced Accelerator Applications USA Inc., a foreign-owned for-profit manufacturer, for the provision of NETSPOT Gallium 68 Injection Kits. The contract does not have a small business set-aside designation. Advanced Accelerator Applications USA Inc. is a radiopharmaceutical company that develops, produces, and commercializes diagnostic and therapeutic nuclear medicine products. They have received numerous...
This delivery order against the Pharmaceuticals and Drugs schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 to Medi-Physics, Inc. for the product DATSACAN L-123 LOFLUPANE. The firm fixed price order has a potential value of $0.00 and requires completion by March 31, 2023. Medi-Physics, Inc. is a subsidiary of General Electric Company which will perform under the name GE. No set-aside designation was used...
This is a firm-fixed price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The award is for the provision of 10 units of the radiopharmaceutical Gallium-68 Dotatate (NETSPOT), which is used for nuclear medicine diagnostic imaging procedures. The contract has a ceiling value of $30,000.00 and a period of performance ending on February 24, 2022. RLS (USA) Inc. holds several indefinite...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. The contract is for the provision of radiopharmaceuticals, including specialized nuclear medicine products such as Ga-68 Dotatate, iodine I-123, and technetium-99m, which are used in diagnostic imaging and cancer treatment procedures for veterans and military personnel. The...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 15 (VISN 15) to Mid-America Isotopes, Inc., a for-profit small disadvantaged business manufacturer of goods. The $1,030,527.78 firm fixed price contract is to provide "LAB RADIOPHARMACEUTICALS" in support of VA healthcare operations, with a period of performance from April 1, 2022 to March 31, 2023. The place of performance is...
This is a contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., for the provision of radiopharmaceuticals needed for medical imaging studies. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) call with a firm-fixed price and a potential value of $48,833.14. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Cardinal Health 414 is a major supplier...
This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $2,387.15 firm fixed-price purchase order is for the supply of various radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, indium-111, thallium-201, fluorine-18 FDG, and gallium-67, as well as the radiopharmaceutical therapy Xofigo (radium-223 dichloride) for prostate cancer treatment. These critical medical...
The Defense Health Agency awarded a $168,497.89 firm fixed price delivery order to Lantheus Medical Imaging, Inc. under the Pharmaceuticals and Drugs GSA Schedule 61-IB contract. The contract is for the provision of radiopharmaceutical products for nuclear medicine, including technetium-99m generators, xenon-133 gas, sestamibi vials, and other nuclear medicine supplies. The contract is set aside for small businesses, and the products will be delivered to the Bethesda, Maryland area. Lantheus...